Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lurie Holdings is a private holding company and investment vehicle associated with Ann Lurie and the Ann and Robert H. Lurie Foundation in Chicago. The organization appears to function primarily as a family office and investment arm rather than as an operating biotech or pharmaceutical company. Through related investment activities commonly referred to as Lurie Investments or the Lurie Investment Fund, it has backed healthcare-related companies in medical devices, therapeutics, diagnostics, and services, as well as some nanotechnology and MEMS businesses. Based on available public information, Lurie Holdings itself does not appear to develop proprietary drug candidates or operate a clinical-stage therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lurie Holdings.